Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GJB2 | P29033 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3878575 | 1.00 | PYGB (0.47) | PYGBMAPK1GAAPRKCAMAPT | |
| SCHEMBL12198733 | 0.98 | PYGB (0.48) | PYGBMAPK1GAAPRKCAGJB2 | |
| SCHEMBL2507136 | 0.98 | PYGB (0.48) | PYGBMAPK1GAAPRKCAGJB2 | |
| SCHEMBL2302510 | 0.98 | PYGB (0.48) | PYGBMAPK1GAAPRKCAGJB2 | |
| SCHEMBL12198736 | 0.86 | LGALS8 (0.53) | MAPK1GJB2KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL10301424 | 0.86 | LGALS8 (0.53) | MAPK1GJB2KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL2794643 | 0.81 | SELP (0.45) | PYGBGAA | |
| SCHEMBL2792078 | 0.81 | SELP (0.45) | PYGBGAA | |
| SCHEMBL27806724 | 0.81 | SELP (0.45) | PYGBGAA | |
| SCHEMBL12088003 | 0.80 | CETP (0.45) | MAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2350108-B1 | C-GLYCOSIDE COMPOUNDS, AND METHOD FOR PREPARING C-GLYCOSIDE COMPOUNDS | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2014-04-30 | — | — | EP | disclosed |
| US-8569467-B2 | C-glycoside compounds, and method for preparing C-glycoside compounds | ECOLE NATIONALE SUPÉRIEURE DE CHIMIE DE RENNES (FR) | 2013-10-29 | — | — | US | disclosed |
| US-20110245490-A1 | C-GLYCOSIDE COMPOUNDS, AND METHOD FOR PREPARING C-GLYCOSIDE COMPOUNDS | ARMOR PROTEINES (FR) | 2011-10-06 | — | — | US | disclosed |
| EP-2350108-A2 | C-GLYCOSIDE COMPOUNDS, AND METHOD FOR PREPARING C-GLYCOSIDE COMPOUNDS | Ecole Nationale Superieure de Chimie de Rennes (FR) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010052314-A2 | C-GLYCOSIDE COMPOUNDS, AND METHOD FOR PREPARING C-GLYCOSIDE COMPOUNDS | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2010-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245490-A1 | C-GLYCOSIDE COMPOUNDS, AND METHOD FOR PREPARING C-GLYCOSIDE COMPOUNDS | FUT5, FUT6, CSGALNACT1 | PYGB 750/4885MAPK1 751/4885GAA 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.